Bosnia and Herzegovina - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Bosnia and Herzegovina Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 24.2% year on year. With 1 Cases in 2019, the country was ranked number 304 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 1.00 |
2018 | 2.00 |
2017 | 0.00 |
2016 | 0.00 |
2015 | 3.00 |
Download all data from 2005 to 2019
How does Bosnia and Herzegovina rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
304 |
#304
Belize
|
1 | 2019 | +0.0 % | NA | View data | |
304 |
#304
Bosnia and Herzegovina
|
1 | 2019 | -50.0 % | -24.2 % | View data | |
304 |
#304
Brunei
|
1 | 2019 | NA | +0.0 % | View data |